ESPE Abstracts (2024) 98 P1-189

ESPE2024 Poster Category 1 Pituitary, Neuroendocrinology and Puberty 3 (9 abstracts)

COVID-19 stressful conditions in the increase of central precocious puberty: long-term follow-up and timelines of this phenomenon demonstrate the declines to pre-pandemic levels after the end of online classes period in Italy.

Stefano Stagi 1,2 , Lorenzo Iughetti 3 , Chiara Sartori 4 , Vittorio Ferrari 5 , Patrizia Bruzzi 3 & Maria Elisabeth street 6


1Meyer Children's Hospital IRCCS, Florence, Italy. 2Health Sciences Department, University of Florence, Florence, Italy. 3Department of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, Modena, Italy. 4Department of Medical and Surgical Sciences of the Mother, Children and Adults, University of Modena and Reggio Emilia, Reggio Emilia, Italy. 5University of Bologna, Bologna, Italy. 6Department of Medicine and Surgery, University of Parma, Parma, Italy


Introduction: COVID-19 pandemic resulted in serious social challenges and physical and mental repercussions. In many countries, central precocious Puberty (CPP) increased dramatically but long-term data are really reduced.

Aim: A retrospective evaluation of incidence and characteristics of CPP before and during COVID-19 pandemic in four Italian Paediatric Hospitals (Florence, Modena, Reggio-Emilia and Parma).

Patients and methods: 449 patients diagnosed by 01 January 2018 to 31 December 2022 were collected. We divided this period in pre-COVID-19 (pre-Cov19: from 01/01/2018 to 08/03/2020) and COVID-19 period (Cov19: from 08/03/2020 to 31/12/ 2022); Cov19 period was further divided into lockdown (lock-Cov19), restrictions (restr-Cov19), post-restriction (postrestr-Cov19) periods.

Results: During pre-Cov19, 111 CPP (7.8 ± 0.6 years) were diagnosed (4.3 cases for month); of these, 7.2% showed a rapidly progressive course (RPPP) and 14.4% were untreated CPP disclosing a RPPP during the lockdown. During Cov19, 338 CPP (7.8 ± 0.9 years) were diagnosed (10.0 cases for month; P < 0.05); among Cov19, we diagnosed 9.8 cases for month (P < 0.05) during lock-Cov19 (7.4 ± 1.2; P < 0.005), 14.4 cases for month (P < 0.0001) during restr-Cov19 (7.7 ± 1.0; P = NS), and 5.4 cases for month (P = NS) during postrestr-Cov19 (7.8 ± 1.0: P = NS). In the Cov19 period 36.7% of CPP were RPPP: 55.5% in lock-Cov19 (P < 0.0001), 36.7% in restr-Cov19 (P < 0.0001) and 8.8% in postrestr-Cov19 (P = NS). Basal LH (BLH), peak LH (PLH), DPLH/BLH, ovary volume and uterine length were significantly different in lock-Cov19 and restr-Cov19, but not postrestr-Cov19, in respect to pre-Cov19. BMI, bone age and height SDS were not different among these groups.

Conclusion: CPP diagnosis significantly increase during the first year of the Covid-19 pandemic in respect to pre-pandemic years and post-restriction year; CPP incidence decrease particularly after the end of online classes at home, stressing the use of electronic devices as one of the main causes of CPP during the COVID-19 pandemic.

Volume 98

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.